SL THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,517 KRW | -14.97% |
|
-22.96% | +157.56% |
| 2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
| 2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SL THERAPEUTICS, INC. | Biopharmaceuticals | -14.97% | -22.96% | +157.56% | +8.05% | -78.83% | 5.72M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- A258540 Stock
- Charts SL Therapeutics, Inc.
- Comparison Chart